Laboratory diagnostic value of neopterin measurements in patients with COVID-19 infection
The new coronavirus SARS-CoV-2 was identified to be responsible for the COVID-19 pandemic. There are striking differences in the response to infection, some people develop no or mild symptoms, while other outcomes are severe of even fatal. For those COVID-19 patients who require hospitalization, pro...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d25e83eb157a4f23b6dec54a3649c65b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d25e83eb157a4f23b6dec54a3649c65b |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d25e83eb157a4f23b6dec54a3649c65b2021-12-05T14:11:02ZLaboratory diagnostic value of neopterin measurements in patients with COVID-19 infection0933-48072195-472010.1515/pteridines-2021-0001https://doaj.org/article/d25e83eb157a4f23b6dec54a3649c65b2021-01-01T00:00:00Zhttps://doi.org/10.1515/pteridines-2021-0001https://doaj.org/toc/0933-4807https://doaj.org/toc/2195-4720The new coronavirus SARS-CoV-2 was identified to be responsible for the COVID-19 pandemic. There are striking differences in the response to infection, some people develop no or mild symptoms, while other outcomes are severe of even fatal. For those COVID-19 patients who require hospitalization, prognostic markers could help clinicians to identify patients with a poor outcome early. The serum levels of the immune activation marker neopterin have already been shown to be of prognostic value in patients with SARS-CoV-1 and a similar pattern can be observed for SARS-CoV-2. This comment discusses the biochemical circuits that support the clinical value of neopterin measurements in COVID-19 patients.Fuchs DietmarGisslen MagnusDe Gruyterarticlecovid-19neopterinlaboratory diagnosticCrystallographyQD901-999ENPteridines, Vol 32, Iss 1, Pp 1-4 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
covid-19 neopterin laboratory diagnostic Crystallography QD901-999 |
spellingShingle |
covid-19 neopterin laboratory diagnostic Crystallography QD901-999 Fuchs Dietmar Gisslen Magnus Laboratory diagnostic value of neopterin measurements in patients with COVID-19 infection |
description |
The new coronavirus SARS-CoV-2 was identified to be responsible for the COVID-19 pandemic. There are striking differences in the response to infection, some people develop no or mild symptoms, while other outcomes are severe of even fatal. For those COVID-19 patients who require hospitalization, prognostic markers could help clinicians to identify patients with a poor outcome early. The serum levels of the immune activation marker neopterin have already been shown to be of prognostic value in patients with SARS-CoV-1 and a similar pattern can be observed for SARS-CoV-2. This comment discusses the biochemical circuits that support the clinical value of neopterin measurements in COVID-19 patients. |
format |
article |
author |
Fuchs Dietmar Gisslen Magnus |
author_facet |
Fuchs Dietmar Gisslen Magnus |
author_sort |
Fuchs Dietmar |
title |
Laboratory diagnostic value of neopterin measurements in patients with COVID-19 infection |
title_short |
Laboratory diagnostic value of neopterin measurements in patients with COVID-19 infection |
title_full |
Laboratory diagnostic value of neopterin measurements in patients with COVID-19 infection |
title_fullStr |
Laboratory diagnostic value of neopterin measurements in patients with COVID-19 infection |
title_full_unstemmed |
Laboratory diagnostic value of neopterin measurements in patients with COVID-19 infection |
title_sort |
laboratory diagnostic value of neopterin measurements in patients with covid-19 infection |
publisher |
De Gruyter |
publishDate |
2021 |
url |
https://doaj.org/article/d25e83eb157a4f23b6dec54a3649c65b |
work_keys_str_mv |
AT fuchsdietmar laboratorydiagnosticvalueofneopterinmeasurementsinpatientswithcovid19infection AT gisslenmagnus laboratorydiagnosticvalueofneopterinmeasurementsinpatientswithcovid19infection |
_version_ |
1718371504861741056 |